CARM logo

CARM
Carisma Therapeutics Inc

38,299
Mkt Cap
$20,923.00
Volume
2,450.00
52W High
$1.27
52W Low
$0.0001
PE Ratio
0.00
CARM Fundamentals
Price
$0.0005
Prev Close
$0.0005
Open
$0.0005
50D MA
$0.0296
Beta
6.20
Avg. Volume
79,227.43
P/B
-0.02
Loading...
Loading...

About

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Carisma Therapeutics Inc?
What is the 52-week high for Carisma Therapeutics Inc?
What is the 52-week low for Carisma Therapeutics Inc?
What is Carisma Therapeutics Inc stock price today?
What was Carisma Therapeutics Inc stock price yesterday?
What is the Price-to-Book ratio of Carisma Therapeutics Inc?
What is the 50-day moving average of Carisma Therapeutics Inc?

Latest CARM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.